Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 17 | 58703195 | splice acceptor variant | G/C;T | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.200 | 17 | 58720795 | frameshift variant | TTGTTCCTGC/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.200 | 17 | 58720795 | frameshift variant | TTGTTCCTGC/- | delins |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
1.000 | 17 | 58724097 | frameshift variant | A/- | delins |
|
0.700 | 1.000 | 1 | 2003 | 2003 | ||||||||||
|
1.000 | 17 | 58732512 | stop gained | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
1.000 | 17 | 58734130 | stop gained | A/T | snv |
|
0.700 | 1.000 | 1 | 2003 | 2003 | ||||||||||
|
0.925 | 0.040 | 17 | 58692526 | upstream gene variant | G/A;C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.925 | 0.040 | 17 | 58692526 | upstream gene variant | G/A;C | snv |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.882 | 0.200 | 17 | 58703201 | stop gained | C/T | snv | 4.0E-05 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 17 | 58692778 | missense variant | G/A;C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 17 | 58692740 | frameshift variant | CA/- | del |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||||
|
1.000 | 17 | 58732523 | stop gained | C/A;T | snv | 8.0E-06 |
|
0.700 | 1.000 | 1 | 2003 | 2003 | |||||||||
|
0.925 | 17 | 58709991 | splice donor variant | G/A;T | snv | 1.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.827 | 0.200 | 17 | 58695189 | stop gained | G/A;C | snv | 4.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 17 | 58695189 | stop gained | G/A;C | snv | 4.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.200 | 17 | 58695189 | stop gained | G/A;C | snv | 4.1E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 17 | 58696811 | frameshift variant | -/C | delins |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
1.000 | 17 | 58694964 | frameshift variant | CT/- | delins |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
17 | 58703244 | frameshift variant | AT/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||||||
|
0.925 | 17 | 58692790 | splice donor variant | T/G | snv |
|
0.700 | 0 | |||||||||||||
|
0.925 | 17 | 58692790 | splice donor variant | T/G | snv |
|
0.700 | 0 | |||||||||||||
|
1.000 | 17 | 58695014 | frameshift variant | G/- | delins |
|
0.700 | 0 | |||||||||||||
|
17 | 58703316 | stop gained | C/G;T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||||
|
0.882 | 0.200 | 17 | 58709884 | frameshift variant | T/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||
|
1.000 | 17 | 58720757 | frameshift variant | ATCA/-;ATCAATCA | delins |
|
0.700 | 0 |